MoonLake Immunotherapeutics
MLTX
#3449
Rank
$3.33 B
Marketcap
$52.91
Share price
-4.61%
Change (1 day)
12.03%
Change (1 year)

Earnings for MoonLake Immunotherapeutics (MLTX)

Earnings in 2024 (TTM): -$0.11 Billion USD

According to MoonLake Immunotherapeutics's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -$54.13 Million USD, an increase over its 2022 earnings that were of -$65.07 Million USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for MoonLake Immunotherapeutics from 2022 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -$0.11 Billion100.54%
2023 -$54.13 Million-16.81%
2022 -$65.07 Million